- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 27th, 2003
Altair Nanotechnologies Testing RenaZorb With 2nd Pharm. Co.
Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced that it has entered into a testing agreement with a second pharmaceutical company for in vivo (animal) evaluation of RenaZorb(TM), its new pharmaceutical candidate for phosphate control in kidney dialysis patients.
|Related News Press|
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016
Hepatitis virus-like particles as potential cancer treatment February 5th, 2016